Skip to content
The Policy VaultThe Policy Vault

SivextroCigna

Continuation of Sivextro therapy in the outpatient setting

Initial criteria

  • Approve for up to 6 days of therapy in patients transitioning from Sivextro IV therapy to oral therapy

Approval duration

6 days